← Eichor
Condition: Immune Response To Covid 19 Vaccination Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immune Response To Covid 19 Vaccination

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COV
Phase 1 · 1 location(s) · The Methodist Hospital Research Institute · NCT06821100Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04794829Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05078905Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress
NA · 1 location(s) · Iowa State University · NCT05213000Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination
Phase N/A · 1 location(s) · University of Bergen · NCT04706390
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.